Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 138 | 139 | 142 | 142 | 142 |
| Accounts receivable | 8 | -11 | 5 | -4 | -2 |
| Other Working Capital | 37 | 25 | -1 | -40 | 11 |
| Other Operating Activity | -234 | -200 | -209 | -177 | -181 |
| Operating Cash Flow | $-51 | $-46 | $-63 | $-80 | $-31 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2 | 117 | N/A | N/A |
| Debt Issued | 145 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3 | -3 | -6 | -6 | -6 |
| Other Financing Activity | -59 | 1 | -1 | 50 | -55 |
| Financing Cash Flow | $83 | $0 | $111 | $44 | $-61 |
| Beginning Cash Position | 9 | 55 | 8 | 47 | 139 |
| End Cash Position | 41 | 9 | 55 | 8 | 47 |
| Net Cash Flow | $32 | $-46 | $47 | $-39 | $-92 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51 | -46 | -63 | -80 | -31 |
| Free Cash Flow | -51 | -46 | -63 | -80 | -31 |